Vivomixx
Sponsors
Seattle Children's Hospital, Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, University College, London, Tel-Aviv Sourasky Medical Center, Lund University
Conditions
Anal DysplasiaAntibiotic Resistant InfectionAutism Spectrum DisorderBreast CancerCirrhosis, LiverEnvironmental Enteric DysfunctionGut Microbiota DysbiosisHIV
Phase 1
Phase 2
Unknown Phase
Pilot Study of Probiotics in Pre-diabetic Adolescents
CompletedNCT03109587
Start: 2018-06-01End: 2020-07-31Updated: 2020-08-21
Effect of Vivomixx® on Neuroinflammation in Patients Withs Cirrhosis
WithdrawnNCT03236090
Start: 2017-07-15End: 2018-03-09Updated: 2018-03-13
Efficacy of Vivomixx on Behaviour and Gut Function in Autism Spectrum Disorder
CompletedNCT03369431
Start: 2018-02-01End: 2021-01-29Updated: 2022-03-08
Can Probiotic Vivomixx Eradicate Colonization With ESBL?
CompletedNCT03860415
Start: 2017-02-01End: 2019-04-30Updated: 2019-05-28
Application of Oral Bacteriotherapy to Promote Anal HPV Clearance in HIV Positive Individuals
NCT04099433
Start: 2019-03-01End: 2020-09-01Target: 40Updated: 2019-09-23
Impact of Probiotics in HIV-positive Patients With Neurocognitive Disorders
CompletedNCT04175223
Start: 2019-09-19End: 2024-05-15Updated: 2024-05-17